Article
Vascular endothelial growth factor A (VEGFA) gene polymorphisms have an impact on survival in a subgroup of indolent patients with chronic lymphocytic leukemia.
PloS one - 1 Jan 2014
Lozano-Santos Carol, Martinez-Velasquez Jimena, Fernandez-Cuevas Belen, Polo Natividad, Navarro Belen, Millan Isabel, Garcia Jose Miguel, Collado Rosa, Sanchez-Godoy Pedro, Carbonell Felix, Garcia-Vela Jose Antonio, Garcia-Marco Jose Antonio, Gomez-Lozano Natalia
Abstract excerpt
Vascular endothelial growth factor (VEGF)-mediated angiogenesis contributes to the pathogenesis of B-cell chronic lymphocytic leukaemia (CLL). We investigated the impact of VEGFA gene diversity on the clinical outcome of patients with this disease. A VEGFA haplotype conformed by positions rs699947 (-1540C>A), rs833061 (-460T>C) and rs2010963 (405C>G) and two additional single-nucleotide polymorphisms (SNPs),...
Read the complete abstract on PubMed